vs
Penumbra Inc（PEN）与Revolve Group, Inc.（RVLV）财务数据对比。点击上方公司名可切换其他公司
Penumbra Inc的季度营收约是Revolve Group, Inc.的1.2倍（$385.4M vs $324.4M），Penumbra Inc净利率更高（12.3% vs 5.7%，领先6.6%），Penumbra Inc同比增速更快（22.1% vs 10.4%），Penumbra Inc自由现金流更多（$68.0M vs $-13.3M），过去两年Penumbra Inc的营收复合增速更高（17.6% vs 9.5%）
Penumbra Inc是2004年由Arani Bose与Adam Elsesser联合创立的美国医疗器械企业，总部位于加利福尼亚州阿拉米达，核心业务为研发、生产中风、动脉瘤等血管疾病介入治疗所用的专业医疗设备，产品已在全球多个国家的临床诊疗场景中投入使用。
Revolve Theatre Company是总部位于英国泰晤士河畔亨利的剧团，专注于创作演出政治题材和莎士比亚系列戏剧作品，由奥利弗·登奇、乔·莫里斯与汤姆·史密斯共同创立运营。
PEN vs RVLV — 直观对比
营收规模更大
PEN
是对方的1.2倍
$324.4M
营收增速更快
PEN
高出11.7%
10.4%
净利率更高
PEN
高出6.6%
5.7%
自由现金流更多
PEN
多$81.3M
$-13.3M
两年增速更快
PEN
近两年复合增速
9.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $385.4M | $324.4M |
| 净利润 | $47.3M | $18.6M |
| 毛利率 | 68.0% | 53.3% |
| 营业利润率 | 15.4% | 6.3% |
| 净利率 | 12.3% | 5.7% |
| 营收同比 | 22.1% | 10.4% |
| 净利润同比 | 40.6% | 50.4% |
| 每股收益（稀释后） | $1.20 | $0.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PENRVLV
| Q4 25 | $385.4M | $324.4M | ||
| Q3 25 | $354.7M | $295.6M | ||
| Q2 25 | $339.5M | $309.0M | ||
| Q1 25 | $324.1M | $296.7M | ||
| Q4 24 | $315.5M | $293.7M | ||
| Q3 24 | $301.0M | $283.1M | ||
| Q2 24 | $299.4M | $282.5M | ||
| Q1 24 | $278.7M | $270.6M |
净利润PENRVLV
| Q4 25 | $47.3M | $18.6M | ||
| Q3 25 | $45.9M | $21.2M | ||
| Q2 25 | $45.3M | $10.2M | ||
| Q1 25 | $39.2M | $11.8M | ||
| Q4 24 | $33.7M | $12.3M | ||
| Q3 24 | $29.5M | $11.0M | ||
| Q2 24 | $-60.2M | $15.4M | ||
| Q1 24 | $11.0M | $10.9M |
毛利率PENRVLV
| Q4 25 | 68.0% | 53.3% | ||
| Q3 25 | 67.8% | 54.6% | ||
| Q2 25 | 66.0% | 54.1% | ||
| Q1 25 | 66.6% | 52.0% | ||
| Q4 24 | 66.8% | 52.5% | ||
| Q3 24 | 66.5% | 51.2% | ||
| Q2 24 | 54.4% | 54.0% | ||
| Q1 24 | 65.0% | 52.3% |
营业利润率PENRVLV
| Q4 25 | 15.4% | 6.3% | ||
| Q3 25 | 13.8% | 7.1% | ||
| Q2 25 | 12.0% | 5.8% | ||
| Q1 25 | 12.4% | 5.0% | ||
| Q4 24 | 13.6% | 3.9% | ||
| Q3 24 | 11.7% | 5.0% | ||
| Q2 24 | -27.0% | 5.8% | ||
| Q1 24 | 4.3% | 3.4% |
净利率PENRVLV
| Q4 25 | 12.3% | 5.7% | ||
| Q3 25 | 12.9% | 7.2% | ||
| Q2 25 | 13.3% | 3.3% | ||
| Q1 25 | 12.1% | 4.0% | ||
| Q4 24 | 10.7% | 4.2% | ||
| Q3 24 | 9.8% | 3.9% | ||
| Q2 24 | -20.1% | 5.4% | ||
| Q1 24 | 3.9% | 4.0% |
每股收益（稀释后）PENRVLV
| Q4 25 | $1.20 | $0.27 | ||
| Q3 25 | $1.17 | $0.29 | ||
| Q2 25 | $1.15 | $0.14 | ||
| Q1 25 | $1.00 | $0.16 | ||
| Q4 24 | $0.88 | $0.18 | ||
| Q3 24 | $0.75 | $0.15 | ||
| Q2 24 | $-1.55 | $0.21 | ||
| Q1 24 | $0.28 | $0.15 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $186.9M | $292.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.4B | $512.5M |
| 总资产 | $1.8B | $765.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PENRVLV
| Q4 25 | $186.9M | $292.3M | ||
| Q3 25 | $321.0M | $315.4M | ||
| Q2 25 | $421.8M | $310.7M | ||
| Q1 25 | $376.1M | $300.8M | ||
| Q4 24 | $324.4M | $256.6M | ||
| Q3 24 | $280.5M | $252.8M | ||
| Q2 24 | $288.3M | $244.7M | ||
| Q1 24 | $223.1M | $273.4M |
股东权益PENRVLV
| Q4 25 | $1.4B | $512.5M | ||
| Q3 25 | $1.4B | $490.2M | ||
| Q2 25 | $1.3B | $468.6M | ||
| Q1 25 | $1.2B | $453.4M | ||
| Q4 24 | $1.2B | $437.8M | ||
| Q3 24 | $1.1B | $420.8M | ||
| Q2 24 | $1.2B | $405.8M | ||
| Q1 24 | $1.2B | $389.9M |
总资产PENRVLV
| Q4 25 | $1.8B | $765.0M | ||
| Q3 25 | $1.7B | $751.3M | ||
| Q2 25 | $1.7B | $722.9M | ||
| Q1 25 | $1.6B | $713.9M | ||
| Q4 24 | $1.5B | $665.5M | ||
| Q3 24 | $1.5B | $670.9M | ||
| Q2 24 | $1.5B | $657.8M | ||
| Q1 24 | $1.6B | $650.0M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $86.5M | $-10.2M |
| 自由现金流经营现金流 - 资本支出 | $68.0M | $-13.3M |
| 自由现金流率自由现金流/营收 | 17.7% | -4.1% |
| 资本支出强度资本支出/营收 | 4.8% | 1.0% |
| 现金转化率经营现金流/净利润 | 1.83× | -0.55× |
| 过去12个月自由现金流最近4个季度 | $174.9M | $48.0M |
8季度趋势，按日历期对齐
经营现金流PENRVLV
| Q4 25 | $86.5M | $-10.2M | ||
| Q3 25 | $58.3M | $11.8M | ||
| Q2 25 | $44.9M | $12.6M | ||
| Q1 25 | $49.0M | $45.1M | ||
| Q4 24 | $51.1M | $3.9M | ||
| Q3 24 | $56.5M | $9.1M | ||
| Q2 24 | $22.6M | $-24.7M | ||
| Q1 24 | $38.3M | $38.4M |
自由现金流PENRVLV
| Q4 25 | $68.0M | $-13.3M | ||
| Q3 25 | $42.0M | $7.5M | ||
| Q2 25 | $29.4M | $10.4M | ||
| Q1 25 | $35.5M | $43.4M | ||
| Q4 24 | $45.7M | $2.1M | ||
| Q3 24 | $51.0M | $8.0M | ||
| Q2 24 | $18.1M | $-25.7M | ||
| Q1 24 | $32.5M | $36.7M |
自由现金流率PENRVLV
| Q4 25 | 17.7% | -4.1% | ||
| Q3 25 | 11.8% | 2.5% | ||
| Q2 25 | 8.7% | 3.4% | ||
| Q1 25 | 11.0% | 14.6% | ||
| Q4 24 | 14.5% | 0.7% | ||
| Q3 24 | 16.9% | 2.8% | ||
| Q2 24 | 6.0% | -9.1% | ||
| Q1 24 | 11.7% | 13.5% |
资本支出强度PENRVLV
| Q4 25 | 4.8% | 1.0% | ||
| Q3 25 | 4.6% | 1.5% | ||
| Q2 25 | 4.6% | 0.7% | ||
| Q1 25 | 4.2% | 0.6% | ||
| Q4 24 | 1.7% | 0.6% | ||
| Q3 24 | 1.8% | 0.4% | ||
| Q2 24 | 1.5% | 0.4% | ||
| Q1 24 | 2.1% | 0.6% |
现金转化率PENRVLV
| Q4 25 | 1.83× | -0.55× | ||
| Q3 25 | 1.27× | 0.56× | ||
| Q2 25 | 0.99× | 1.24× | ||
| Q1 25 | 1.25× | 3.82× | ||
| Q4 24 | 1.52× | 0.32× | ||
| Q3 24 | 1.91× | 0.83× | ||
| Q2 24 | — | -1.60× | ||
| Q1 24 | 3.48× | 3.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PEN
| Thrombectomy | $254.7M | 66% |
| Other | $130.7M | 34% |
RVLV
| Fashion Apparel | $155.1M | 48% |
| Dresses | $76.4M | 24% |
| Handbags Shoes And Accessories | $67.6M | 21% |
| Beauty | $20.3M | 6% |
| Manufactured Product Other | $5.0M | 2% |
| Breakage On Store Credit And Gift Cards | $900.0K | 0% |
